Apitherapy & Bee Venom
Healing Stings, Ancient Claim and Real Risk
Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.
The honest verdict separates one validated use from many unproven ones. The validated use is the reverse of what apitherapy proposes: standardized bee-venom immunotherapy (desensitization) is an accepted, effective mainstream treatment to protect people with dangerous bee-sting allergies from anaphylaxis. For the therapeutic claims of BVT, treating arthritis, MS, chronic pain, autoimmune and other conditions, clinical evidence is inconclusive and mixed, and a common expert conclusion is that there is not enough evidence of benefit to justify the pain, swelling, and anaphylaxis risk; some reviewers advise physicians not to recommend BVT for arthritis or MS on that risk-benefit basis. Laboratory interest in melittin (including exploratory antiviral and anticancer work) is real but does not equate to proven therapy. So: validated for allergy desensitization, unproven and risk-laden for the conditions apitherapy markets it for.
Reference only. Not medical advice.
What can go wrong
Bee venom therapy carries a serious, documented danger of anaphylaxis, a rapid whole-body allergic reaction that can close the airway and collapse blood pressure within minutes. Roughly 5 to 7.5% of people will have a severe systemic reaction to an insect sting at some point in life, with the risk sharply higher among beekeepers and the frequently stung, and a person can react even after tolerating many prior stings. In 2018 the Journal of Investigational Allergology and Clinical Immunology reported the first death from bee venom apitherapy, a Spanish woman who had had sessions every four weeks for two years and then suffered fatal anaphylaxis leading to stroke, coma, and multiorgan failure. Beyond allergy, repeated stinging causes pain and local swelling, and the practice is largely unregulated with no required training in many places and, critically, often no immediate access to adrenaline. It is a poor fit for pregnancy and for anyone with cardiovascular disease or any prior sting reaction. Anyone weighing it should first talk with a qualified allergist or physician, undergo allergy assessment, and never receive it where emergency treatment for anaphylaxis is unavailable. The validated desensitization version is a different, medically supervised procedure.
Apitherapy is the medicinal use of bee products, and it is genuinely ancient. Honey, beeswax, and bee venom for wounds and joint pain are recorded in Egypt's Ebers Papyrus around 1550 BCE, in Greek and Roman writing, and in several thousand years of Chinese practice. Its most contested form is bee venom therapy, which applies live stings or injected venom for arthritis, chronic pain, and more recently multiple sclerosis. The venom's main peptide, melittin, is a real anti-inflammatory in the laboratory, which gives the practice a plausible rationale, but that work is almost entirely in cells and animals, and the human trials that exist are few, small, and largely negative. The one bee-venom use with strong medical backing is the opposite of the therapy: standardized venom immunotherapy that desensitizes people with dangerous sting allergies. The reason this entry carries such a heavy caution is anaphylaxis. In 2018 a Spanish woman who had tolerated live-bee sessions for two years died of anaphylactic complications, the first such death reported in the allergy literature.
An ancient bee-sting therapy with a real anti-inflammatory rationale but inconclusive evidence and a serious, documented anaphylaxis risk, including deaths.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Bee venom contains potent bioactive compounds, chiefly melittin (anti-inflammatory and cytotoxic in the lab), along with peptides and enzymes (phospholipase A2). These have real pharmacological activity and are of genuine research interest, giving a plausible rationale for anti-inflammatory effects. But the same potency drives the danger: phospholipase A2 and other components are major allergens, capable of triggering severe, even fatal, allergic reactions in sensitized people.
What people get wrong
Often saidBee venom therapy is a proven natural treatment for arthritis and MS.
ActuallyThe therapeutic evidence is thin and largely negative. A 2014 BMJ Open review of bee venom acupuncture for rheumatoid arthritis found only one qualifying RCT and rated the evidence low quality, and the 2005 Wesselius crossover trial in Neurology found no benefit in multiple sclerosis on disability, fatigue, relapse rate, MRI lesions, or quality of life. Melittin's anti-inflammatory activity is real but sits almost entirely in cell and animal studies, not validated human therapy.
Often saidBee venom therapy is safe because bee products are natural.
ActuallyBee venom is a potent allergen. Around 5 to 7.5% of people will have a severe systemic reaction to an insect sting at some point, and the risk is far higher for beekeepers and the frequently stung. In 2018 the Journal of Investigational Allergology and Clinical Immunology reported the first death from bee venom apitherapy, a woman who had tolerated sessions for two years before fatal anaphylaxis, associated with the practice often being done without adrenaline on hand.
Often saidIf venom immunotherapy works for allergy, bee venom therapy must work for disease.
ActuallyThese are close to opposites. Venom immunotherapy is a standardized, medically supervised desensitization that trains the immune system to tolerate stings and is roughly 75 to 98% protective against sting anaphylaxis (EAACI 2018). Bee venom therapy instead delivers stings or venom hoping to treat unrelated conditions such as arthritis or MS, and that use is not validated.
Often saidThe bee-venom-for-arthritis text is the Edwin Smith Papyrus.
ActuallyThe bee products used for wounds and joints trace to Egypt's Ebers Papyrus, dated to about 1550 BCE, which records well over a hundred honey remedies. The Edwin Smith Papyrus is a separate surgical and trauma manual and is not the source for bee venom arthritis use.
Who profits, and who pushes back
Allergy/immunology medicine
Uses standardized bee-venom immunotherapy as an effective, accepted treatment to desensitize people with life-threatening sting allergies, distinct from therapeutic BVT.
Apitherapy proponents
Promote bee venom therapy for arthritis, MS, pain, and autoimmune conditions, largely on historical use and anecdotal evidence.
Clinical reviewers
Conclude there is not enough evidence of benefit to justify the pain, swelling, and anaphylaxis risk, and advise physicians not to recommend BVT for arthritis or MS.
Emergency medicine
Document severe systemic reactions and deaths from BVT, including a 2018 "live bee acupuncture" fatality, and stress allergy testing and adrenaline access.
Where the research comes from
Most of the published research on this comes from one place. 75% of it is from Ancient Egypt, Greece, China. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Ancient Egypt, Greece, China | 75% |
| Europe & East Asia (BVT) | 72% |
| Global folk/alt-medicine use | 60% |
How we got here
Bee medicine is among the oldest documented healing traditions and did not begin in Europe. Egypt's Ebers Papyrus, dated to roughly 1550 BCE, records honey in well over a hundred external and internal remedies and is repeatedly cited for bee venom applied to arthritic joints. Chinese practice describes bee stings and bee products across several thousand years, folded into acupuncture-style point stimulation. Greek and Roman writers, Hippocrates among them, mention venom for joint pain. Beekeeping cultures in the Middle East, South Asia, and the Balkans carried folk use forward. The modern therapeutic revival is usually traced to the Austrian physician Philipp Terc, whose 1888 report linked bee stings to relief of rheumatism after he treated his own condition. The Hungarian-born physician Bodog Beck later brought bee venom therapy to the United States and published on it in 1935. Through the twentieth century, enthusiasm for the therapy ran alongside the separate, evidence-based development of venom immunotherapy for allergy, and repeated reports of severe reactions kept tempering the therapeutic claims.
- ~1550 BCEEgypt's Ebers Papyrus records honey remedies and is cited for bee venom on arthritic joints
- AntiquityChinese practice and Greek/Roman writers, including Hippocrates, describe bee venom for joint pain
- 1888Austrian physician Philipp Terc reports a link between bee stings and rheumatism relief
- 1935Bodog Beck popularizes bee venom therapy in the United States with a book on rheumatic arthritis
- 2005Wesselius crossover RCT in Neurology finds bee sting therapy gives no benefit in multiple sclerosis
- 2014BMJ Open systematic review finds only one low-quality RCT of bee venom acupuncture for rheumatoid arthritis
- 2018JIACI reports the first death from bee venom apitherapy anaphylaxis, a Spanish woman previously tolerant
How it is understood
Apitherapy, the medicinal use of bee products (venom, honey, propolis, pollen, royal jelly), is genuinely ancient. The use of bee stings to treat joint pain and arthritis is described in the Edwin Smith Surgical Papyrus (~2000 BCE), in Hippocrates, and in 2,000-year-old Chinese texts, and figures like Charlemagne were said to have used it. Its best-known form is bee venom therapy (BVT), the deliberate application of bee stings (or injected venom) to a site, traditionally for arthritis, rheumatism, and pain, and more recently promoted for multiple sclerosis and other conditions. The practice persisted in European and Asian folk medicine and was revived in the modern era, modern study is often dated to an 1888 report linking bee stings and rheumatism. Honey and propolis, the gentler, evidence-supported corners of apitherapy, are covered elsewhere; this entry centers on the venom, where the claims are big and the risks are real.
At a glance
- Ancient sources
- Edwin Smith Papyrus, Hippocrates, Chinese texts
- Active compound
- Melittin (and phospholipase A2)
- Validated use
- Venom immunotherapy (allergy desensitization)
- Key risk
- Anaphylaxis, including deaths
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Apitherapy & Bee Venom. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
First reported death from bee venom apitherapy anaphylaxis; patient previously tolerant; authors call the practice unsafe and unadvisable
Bee venom acupuncture for rheumatoid arthritis: only 1 qualifying RCT, low-quality evidence, efficacy not established
Lee JA, Son MJ, Choi J, Jun JH, Kim JI, Lee MS. BMJ Open 2014;4(11):e006140
Randomized crossover trial: bee sting therapy gives no benefit in multiple sclerosis (disability, fatigue, relapse, MRI, quality of life)
Melittin's NF-kB anti-inflammatory mechanism, dose-dependent toxicity/hemolysis, and near-absence of validating human trials
Lee G, Bae H. Anti-Inflammatory Applications of Melittin. Molecules 2016;21(5):616
Venom immunotherapy for Hymenoptera allergy is guideline-endorsed and roughly 75-98% protective against sting anaphylaxis
Sturm GJ et al. EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. Allergy 2018
Propolis for recurrent aphthous stomatitis: possible benefit but very low certainty of evidence (GRADE)
Roughly 5-7.5% of people will have a severe systemic sting reaction in life, higher in beekeepers; sensitization 9-42%
Allergy and sensitization to Hymenoptera venoms in unreferred adults with high sting exposure (PMC)
Melittin is ~50% of dry bee venom; bee venom and melittin activity is largely preclinical
Ebers Papyrus (~1550 BCE) records honey in over a hundred remedies and is cited for bee venom on arthritic joints; Egypt/Greece/China history
Bee venom therapy not FDA-approved except for allergy desensitization; apitherapy treated as experimental
National FDA public health warning against unregistered bee-venom topical drug product
Modern revival: Philipp Terc 1888 rheumatism report and Bodog Beck bringing BVT to the US (1935)